← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2016Last known activity
Mar 31, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT07277998Lead sponsorN/AMar 31, 2026
- NCT07277998OfficialN/AMar 31, 2026
- NCT07277998Sponsor investigatorN/AMar 31, 2026
- NCT05777122Lead sponsorPhase 2Jan 10, 2022
- NCT05777122Overall official - principal investigatorPhase 2Jan 10, 2022
- NCT05777122Sponsor investigatorPhase 2Jan 10, 2022
- NCT04302532Lead sponsorPhase 4Apr 3, 2020
- NCT04302532Study directorPhase 4Apr 3, 2020
- NCT04302532Reponsible party - principal investigatorPhase 4Apr 3, 2020
- NCT02758340Lead sponsorPhase 3Apr 1, 2016
- NCT02758340Overall official - principal investigatorPhase 3Apr 1, 2016
- NCT02758340Reponsible party - principal investigatorPhase 3Apr 1, 2016
Details
- Last known activity
- Mar 31, 2026